Conferences
Upcoming Journal Conferences (1)

Online
Cardiomyopathies include several heart muscle diseases that are often incompletely defined in terms of cause and pathway and often poorly responsive to the proposed treatment. Even in largely recognized entities such as myocarditis, the adoption of the effective therapy is still debated and the agents involved are being increasingly identified by the new-generation sequencing technique. In fact, the morphomolecular investigation of endomyocardial biopsy samples appears to be inevitable to obtain a personalized and most effective treatment.
Regarding the origin of cardiac electrical instability, the direct involvement of conduction tissue (CT) is recognizable in endomyocardial biopsy examination and the possibility to explore CT damage through the determination of CT main molecular complex HCN4 in the peripheral blood appears as a likely prospective option. Many rare diseases phenotyipically present as cardiomyopathies and their definition and identification are crucial for appropriate management.
Nevertheless, even the administration of the lacking molecular component (i.e., enzyme replacement therapy—ERT) can be clinically unsatisfactory. Recently, it has been shown that ERT delivery can be limited in Fabry disease cardiomyopathy by a reduced expression of mannose-6-phosphate receptor that provides its uptake at the level of cell membrane as well as its targeting into lysosomes.
The aim of the present webinar is to update the latest morpho-molecular and genetic knowledge in cardiomyopathy.
Date: 11 December 2025
Time: 2:00 p.m. CET | 8:00 a.m. EST | 9:00 p.m. CST Asia
Webinar ID: 875 7695 1210
Website: https://sciforum.net/event/Biomedicines-19
Register now for free!
| Speaker/Presentation | Time in CET | Time in EST | Time in CST Asia |
| Prof. Dr. Andrea Frustaci Chair Introduction |
2:00–2:10 p.m. | 8:00–8:10 a.m. | 9:00–9:10 p.m. |
| Prof. Dr. Andrea Frustaci Morpho-Molecular Substrate of Resistance to Enzyme Replacement Therapy in Fabry Disease Cardiomyopathy |
2:10–2:30 p.m. | 8:10–8:30 a.m. | 9:10–9:30 p.m. |
| Prof. Dr. Heinz-Peter Schultheis Diagnosis and Treatment of Viral Inflammatory Cardiomyopathy |
2:30–2:50 p.m. | 8:30–8:50 a.m. | 9:30–9:50 p.m. |
| Prof. Dr. Matteo Antonio Russo Electron-Microscopy in Human Cardiomyopathies |
2:50–3:10 p.m. | 8:50–9:10 a.m. | 9:50–10:10 p.m. |
| Prof. Dr Alessandro De Luca Novel Genetic Contributes to Characterization of Cardiomyopathies |
3:10–3:30 p.m. | 9:10–9:30 a.m. | 10:10–10:30 p.m. |
| Q&A Session | 3:30–3:45 p.m. | 9:30–9:45 a.m. | 10:30–10:45 p.m. |
| Prof. Dr. Andrea Frustaci Closing of Webinar |
3:45–3:50 p.m. | 9:45–9:50 a.m. | 10:45–10:50 p.m. |
After registering, you will receive a confirmation email outlining how to join this webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Prof. Dr. Andrea Frustaci, Cellular and Molecular Cardiology Lab, National Institute for Infectious Diseases L. Spallanzani, Rome, Italy;
- Prof. Dr. Heinz-Peter Schultheiss, Institut Kardiale Diagnostik und Therapie (IKDT), Berlin, Germany;
- Prof. Dr. Matteo Antonio Russo, IRCCS San Raffaele Rome, Italy;
- Prof. Dr. Alessandro De Luca, Medical Genetics Laboratory, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Relevant Special Issue:
“Morpho-Molecular and Genetic Basis of Cardiomyopathies”
Guest Editor: Prof. Dr. Andrea Frustaci
Deadline for manuscript submissions: 30 June 2026
Upcoming MDPI Conferences (2)

Barcelona, Spain
We cordially invite you to attend this event organized by MDPI’s Nutrients (ISSN: 2072-6643, impact factor: 5.0, CiteScore: 9.1). It will take place on 22–24 October 2026, CEST, in Barcelona, Spain.
Conference Chairs
- Prof. Dr. Maria Luz Fernandez, University of Connecticut, USA;
- Prof. Dr. Lluis Serra Majem, University of Las Palmas de Gran Canaria, Spain.
The Topics of Interest
S1. Personalized nutrition based on diet–gene interactions;
S2. Innovations in clinical nutrition;
S3. Novel dietary recommendations for specific chronic diseases;
S4. Understanding the role of microbiota in clinical practice;
S5. The potential role of AI in clinical practice;
S6. Lifestyle and prevention of chronic diseases.
Important Dates
Deadline for abstract submissions: 24 June 2026;
Notification of acceptance: 20 July 2026;
Deadline for Early Bird registration: 24 July 2026;
Deadline for Covering Author registration: 24 July 2026.
Guide for Authors
To submit your abstract, please click on the following link:
https://sciforum.net/user/submission/create/1496.
To register for the event, please click on the following link:
https://sciforum.net/event/Nutrients2026?section=#registration.
For details regarding abstract submission, poster and slide submission, and publication opportunities, you may refer to the “Instructions for Authors” section below: https://sciforum.net/event/Nutrients2026?section=#instructions.
For any enquiries regarding the event, please contact nutrients2026@mdpi.com.
We look forward to seeing you at Nutrients 2026.

Beijing, China
This conference is organized by the MDPI journal Molecules (ISSN: 1420-3049, IF: 4.2, and CiteScore: 7.4) and will take place in Beijing, China, from 14 to 17 May 2026 (Beijing time).
Conference Chairs
- Prof. Dr. Xiaoguang Lei, College of Chemistry and Molecular Engineering, Peking University, China;
- Prof. Dr. Diego Muñoz-Torrero, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Spain.
Topics of Interest
S1. Chemical Biology for Drug Discovery;
S2. AI for Drug Discovery;
S3. New Proximity-Based Drug Modalities;
S4. Natural Products in Drug Discovery;
S5. Biocatalysis for Natural Product and Drug Synthesis;
S6. Drug Discovery Targeting GPCRs and Ion Channels;
S7. DNA-Encoded Libraries in Drug Discovery;
S8. Medicinal Chemistry Tales.
Important Dates
Deadline for abstract submission: 16 January 2026;
Abstract acceptance notification: 9 February 2026;
Early bird registration deadline: 11 February 2026;
Covering author registration deadline: 11 February 2026;
Registration deadline: 14 May 2026.
Guide for Authors
To submit your abstract, please visit the following link: https://sciforum.net/user/submission/create/1319.
To register for the event, please visit the following link: https://sciforum.net/event/MMCS2026?section=#registration.
For more information, you may refer to the following link:
https://sciforum.net/event/MMCS2026.
For any inquiries regarding the event, please contact mmcs2026@mdpi.com.
We look forward to seeing you at the 5th MMCS: New Trends in Chemical Biology and Drug Discovery.
